- Home
- LCUT vs CUE Comparison
LCUT vs CUE Comparison
Compare LCUT & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCUT
- CUE
- Stock Information
- Founded
- LCUT 1945
- CUE 2014
- Country
- LCUT United States
- CUE United States
- Employees
- LCUT N/A
- CUE N/A
- Industry
- LCUT Industrial Machinery/Components
- CUE Biotechnology: Pharmaceutical Preparations
- Sector
- LCUT Consumer Discretionary
- CUE Health Care
- Exchange
- LCUT Nasdaq
- CUE Nasdaq
- Market Cap
- LCUT 69.1M
- CUE 61.1M
- IPO Year
- LCUT 1991
- CUE 2018
- Fundamental
- Price
- LCUT $3.13
- CUE $0.69
- Analyst Decision
- LCUT Buy
- CUE Strong Buy
- Analyst Count
- LCUT 2
- CUE 2
- Target Price
- LCUT $5.00
- CUE $3.00
- AVG Volume (30 Days)
- LCUT 58.2K
- CUE 215.0K
- Earning Date
- LCUT 11-06-2025
- CUE 11-12-2025
- Dividend Yield
- LCUT 5.56%
- CUE N/A
- EPS Growth
- LCUT N/A
- CUE N/A
- EPS
- LCUT N/A
- CUE N/A
- Revenue
- LCUT $659,066,000.00
- CUE $8,286,000.00
- Revenue This Year
- LCUT N/A
- CUE N/A
- Revenue Next Year
- LCUT $2.43
- CUE N/A
- P/E Ratio
- LCUT N/A
- CUE N/A
- Revenue Growth
- LCUT N/A
- CUE N/A
- 52 Week Low
- LCUT $2.89
- CUE $0.54
- 52 Week High
- LCUT $7.05
- CUE $1.99
- Technical
- Relative Strength Index (RSI)
- LCUT 36.61
- CUE 38.85
- Support Level
- LCUT $2.90
- CUE $0.68
- Resistance Level
- LCUT $3.78
- CUE $0.79
- Average True Range (ATR)
- LCUT 0.24
- CUE 0.07
- MACD
- LCUT -0.03
- CUE -0.01
- Stochastic Oscillator
- LCUT 18.18
- CUE 6.27
About LCUT Lifetime Brands Inc.
Lifetime Brands Inc is a U.S. based company that designs, sources, and sells branded kitchenware, tableware, and other products used in the home and markets its products under brands such as Farberware, KitchenAid, Mikasa, and others. The company markets and sells its products principally on a wholesale basis to retailers. It also markets and sells a limited selection of its products directly to consumers through its Pfaltzgraff, Mikasa, Fred, and Friends, Built NY, and others. Its products include kitchen tools, gadgets, cutlery, dinnerware, and glassware. The segments of the company are the U.S. and International. It derives a majority of its revenue from the U.S. segment. The company derives maximum revenue from Kitchenware products.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.